BSE filing, BSE: 531997. Summary written from the filing by ALFA Finder's alert engine.
Ikoma Technologies Ltd: key numbers
- Share price
- ₹62.49
- Market cap
- ₹145.0 Cr
- Revenue (annual)
- ₹1.66 Cr
- Net profit (annual)
- ₹0.23 Cr
- P/E (TTM)
- -184.5×Sector 23.0×
- Promoter holding
- 37.72%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ikoma Technologies Ltd
All →Ikoma Technologies Annual General Meeting
Ikoma Technologies Limited concluded its 32nd Annual General Meeting on 30th September 2026, where shareholders transacted various ordinary and special business items.
Ikoma Technologies Merger & Restructuring
Ikoma Technologies Limited has withdrawn its Rights Issue application and the proposed acquisition of ICM Insurance Brokers Private Limited. The withdrawal follows a revision in the Rights Issue objects.
Ikoma Technologies Annual Report
Ikoma Technologies Limited has submitted its 32nd Annual Report for the financial year 2025-26, which includes the notice for the upcoming Annual General Meeting.
Ikoma Technologies Annual General Meeting
Ikoma Technologies Ltd issued a notice for its 32nd Annual General Meeting to be held on September 30, 2026, via video conferencing.
Ikoma Technologies Q1 FY27 Results: Net Profit ₹0 Cr
Ikoma Technologies Ltd reported revenue from operations of ₹0.1 Cr (-94.1% YoY) and net profit of ₹0 Cr for Q1 FY27.
- Key figure
- Net profit ₹0 Cr
Ikoma Technologies Board Meeting Date
Ikoma Technologies Ltd has scheduled a board meeting for August 13, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.